On 9 October 2026, Purapharm Corporation Limited announced that the Extraordinary General Meeting (EGM) circular and related notice are now available in both English and Chinese on the HKEXnews website and the company’s corporate site. The documents will not be distributed in hard copy unless explicitly requested.

The company confirmed that, with effect from HKEX Listing Rule 2.07—part of the exchange’s paperless listing initiative introduced on 31 December 2023—Purapharm has adopted electronic dissemination for all future corporate communications. These materials include annual and interim reports, meeting notices, circulars, proxy forms and listing documents.

Key operational details for shareholders:

• Non-registered shareholders must provide a functional email address to their banks, brokers, custodians, nominees or HKSCC Nominees Limited to receive email notifications when new corporate communications are published.

• Until an email address is on record, shareholders will not receive electronic alerts and must monitor www.purapharm.com and www.hkexnews.hk for updates.

• Printed copies remain available free of charge upon request. Shareholders may submit requests by emailing purapharm.ecom@computershare.com.hk or by writing to the Hong Kong share registrar, Computershare Hong Kong Investor Services Limited, 17M/F, Hopewell Centre, 183 Queen’s Road East, Wanchai, Hong Kong.

• Enquiries can be directed to the share registrar at +852 2862 8688 during business hours.

The notification aligns Purapharm’s investor communications with HKEX’s ongoing digital transformation, aiming to enhance efficiency and reduce paper consumption while ensuring shareholders retain the option to receive physical documentation on demand.